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We describe the case of a 67-year-old female with three subcutaneous nodules that had 
been present for the previous 10 days. She suffered from type 2 diabetes mellitus for 
10 years and had undergone heart transplantation for dilated cardiomyopathy 1 year 
earlier and was undergoing immunosuppression with prednisone 7.5 mg/day, 
tacrolimus 4 mg/day, and sirolimus 1 mg/day. She was febrile (38--39°C) and reported 
to have severe asthenia. She denied any respiratory, gastrointestinal, or urinary 
complaints. There was no palpable lymphadenopathy or hepatosplenomegaly. Chest 
examination revealed decreased breath sounds and dullness to percussion at the right 
base. Dermatological examination disclosed three firm and well-demarcated 
erythematous subcutaneous nodules, 2 cm in diameter, on the left thigh, abdomen, and 
right infraclavicular area [Figure 1]. Nodules were only slightly painful. 
 
Thoracic radiological evaluation documented a right pleural effusion and a large 
nodular opacity in the right inferior pulmonary lobe. Multiple cytological and 
histological examinations did not reveal neoplastic cells.
Figure 1: Skin lesion on the abdomen: erythematous 
subcutaneous nodule 
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Histopathological analysis of the skin lesions revealed a massive dermal and 
hypodermic neutrophilic infiltration [Figure 2], and wide, septated, uniform hyphae 
were identified on periodic acid Schiff stain [Figure 3]. Skin culture as well as 
bronchial aspirate culture isolated Aspergillus fumigatus. Blood cultures were 
persistently negative for bacteria and fungi. Antihuman immunodeficiency virus 
serology was negative. 
Figure 2: Dermal and hypodermic neutrophilic 
infiltration (H and E, ×200) 
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Figure 3: Septated and branching hyphae (Periodic 
Acid Schiff, ×200; inset: ×40) 
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The patient was diagnosed with cutaneous aspergillosis secondary to pulmonary 
aspergillosis. Insulin therapy was provided to achieve optimal glycemic control. She 
was started on therapy with liposomic amphotericin B (L AmB) at 5 mg/kg body 
weight/day intravenously while maintaining the immunosuppressive drugs. About 2 
weeks later, following aggravation of the condition with the emergence of new skin 
lesions, L AmB and sirolimus were suspended, tacrolimus was reduced to 1.5 mg/day, 
and voriconazole (VOR) was started at 5 mg/kg body weight twice daily orally. 
Although a clinical improvement was observed almost immediately after 2 days of 
therapy, followed 7 days later by the regression of skin lesions, the patient died of an 
extensive acute ischemic cerebrovascular disease after 3 weeks of using VOR, which 
was confirmed by brain computed tomography. 
 
Fungal infections can cause significant morbidity and even mortality among transplant 
recipients. After Candida, Aspergillus is the most common genus causing 
opportunistic fungal infections in these patients. [1] It includes over 185 species, but 
the most common causative agents of opportunistic infections in humans are 
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Aspergillus flavus, A. fumigatus, A. niger, A. terreus, and A. ustus.[2]  
 
Cutaneous lesions are rare and are usually due to hematogenous dissemination from an 
underlying infected organ, more commonly the lungs - secondary cutaneous 
aspergillosis (SCA). More rarely, cutaneous lesions are due to direct inoculation - 
primary cutaneous aspergillosis - especially in the settings of burns or trauma. Risk 
factors for invasive aspergillosis include prolonged and severe neutropenia, 
glucocorticoid therapy, hematopoietic stem cell or solid-organ transplantation, 
advanced acquired immunodeficiency syndrome, and chronic granulomatous disease. 
[3]
 Cutaneous lesions occur in 5-10% of the patients with invasive aspergillosis and, on 
rare occasions, can be the presenting sign of systemic infection, as had occurred in our 
patient. In the presenting case, multiple subcutaneous nodules were the revealing 
lesions of SCA. When the histopathological examination of the cutaneous lesion 
revealed findings consistent with aspergillosis, a pulmonary primary focus of infection 
was searched for and found in our patient. Although the radiological findings pointed 
out to pulmonary neoplasia, this was not confirmed by various histopathological and 
cytological samples that, indeed, confirmed the infectious nature of the pulmonary 
mass.  
 
Amphotericin B has been the classical antifungal drug of choice. As the initial therapy 
for invasive aspergillosis, VOR has shown better response rates, improved survival, 
and fewer severe adverse effects compared with amphotericin B. [4],[5] Itraconazole and 
caspofungin are other treatment options. In our patient, who was undergoing 
immunosuppression with prednisone, tacrolimus, and sirolimus, L AmB was the initial 
choice to maintain the immunosuppressive drugs because VOR may significantly 
increase the plasma concentrations of sirolimus, making it mandatory to suspend it.  
 
Early diagnosis and prompt treatment are crucial in the setting of cutaneous 
aspergillosis, especially in SCA, as it represents an invasive infection with major 
morbidity and mortality potentials. Therefore, cutaneous nodular lesions arising in the 
setting of immunosuppression should always lead to search for a systemic infectious 
focus. 
 
This case has the particularity to demonstrate the risk of fungal infections in transplant 
recipients even after 1 year of immunosuppression. Previous reports refer to this as a 
complication occurring in the early posttransplant course. Also, it reminds us that 
cerebrovascular disease is a leading cause of death in the elderly people, particularly 
those with diabetes mellitus. 
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